BUTALBITAL, ACETAMINOPHEN, CAFFEINE, AND CODEINE PHOSPHATEcapsule [Bryant Ranch Prepack]
Updated Date: Jun 15, 2011 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))
FDA panel votes against wider use of Amgen drug
WASHINGTON (Reuters) - An advisory panel on Wednesday recommended that U.S. health regulators reject the use of Amgen Inc's drug Xgeva to delay the spread of prostate cancer to the bone, dimming the chance of a wider use for one of the company's key growth drivers. (Source: Reuters: Health)